Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

NHI

Live52w low +8.5%

Annual Quarterly

Core line items from NHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Annual Quarterly

Entity: National Health Investors, Inc.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-04	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$108.81M	$37.06M	$80.06M	$49.33M	$28.16M
Operating Income	Not available	Not available	Not available	Not available	Not available
Net Income	Not available	$40.10M	$142.18M	$104.01M	$71.15M
EPS (Diluted)	$0.88	$0.82	$3.02	$2.22	$1.53
Total Assets	Not available	$2.89B	$2.80B	$2.69B	$2.70B
Total Liabilities	Not available	$1.36B	$1.26B	$1.19B	$1.20B
Cash & Equivalents	Not available	$24.95M	$19.62M	$81.63M	$18.64M
Free Cash Flow OCF − CapEx	Not available	$-55.98M	$-57.47M	$18.09M	Not available
Shares Outstanding	Not available	48.30M	48.30M	45.69M	45.69M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from NHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +8.5%

Entity: National Health Investors, Inc.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-04	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$108.81M	$37.06M	$80.06M	$49.33M	$28.16M
Operating Income	Not available	Not available	Not available	Not available	Not available
Net Income	Not available	$40.10M	$142.18M	$104.01M	$71.15M
EPS (Diluted)	$0.88	$0.82	$3.02	$2.22	$1.53
Total Assets	Not available	$2.89B	$2.80B	$2.69B	$2.70B
Total Liabilities	Not available	$1.36B	$1.26B	$1.19B	$1.20B
Cash & Equivalents	Not available	$24.95M	$19.62M	$81.63M	$18.64M
Free Cash Flow OCF − CapEx	Not available	$-55.98M	$-57.47M	$18.09M	Not available
Shares Outstanding	Not available	48.30M	48.30M	45.69M	45.69M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.